feed,title,long_url,short_url
Benzinga,Eli Lilly-Vir Bamlanivimab-VIR-7831 Combo Reduces Viral Load By 70% In Low-Risk COVID-19 Patients,https://benzinga.com/general/biotech/21/03/20381785/eli-lilly-vir-bamlanivimab-vir-7831-combo-reduces-viral-load-by-70-in-low-risk-covid-19-patients,https://j.mp/3dhBUfH
